|Day Low/High||1.01 / 1.06|
|52 Wk Low/High||0.70 / 2.05|
VANCOUVER, June 6, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) announced today that construction of the Phase 2 expansion at AB Laboratories Inc.
These stocks trading for less than $10 a share are within range of breaking out and trading higher from current levels.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.